2024-04-25Zeitschriftenartikel
Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023
| dc.contributor.author | Otto-Knapp, Ralf | |
| dc.contributor.author | Edwards, Suzanne | |
| dc.contributor.author | Kuchukhidze, Giorgi | |
| dc.contributor.author | Kröger, Stefan | |
| dc.contributor.author | Häcker, Brit | |
| dc.contributor.author | Bivoli, Stela | |
| dc.contributor.author | Yedilbayev, Askar | |
| dc.date.accessioned | 2026-04-27T07:59:08Z | |
| dc.date.available | 2026-04-27T07:59:08Z | |
| dc.date.issued | 2024-04-25 | none |
| dc.identifier.other | 10.2807/1560-7917.ES.2024.29.17.2400211 | |
| dc.identifier.uri | http://edoc.rki.de/176904/13672 | |
| dc.description.abstract | The BPaLM regimen (bedaquiline, pretomanid, linezolid and moxifloxacin) recently recommended by the World Health Organization offers short, safe, and effective treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB). In a survey with national TB focal points in 18 central and western European countries to explore barriers for the implementation of BPaLM, only three reported full availability of pretomanid, a necessary component of this regimen. Implementation barriers included financing and procurement. Solutions on national and supranational level are needed to guarantee universal access. | eng |
| dc.language.iso | eng | none |
| dc.publisher | Robert Koch-Institut | |
| dc.rights | (CC BY 3.0 DE) Namensnennung 3.0 Deutschland | ger |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/de/ | |
| dc.subject | Europe | eng |
| dc.subject | MDR/RR-TB | eng |
| dc.subject | access | eng |
| dc.subject | drug availability | eng |
| dc.subject | pretomanid | eng |
| dc.subject | tuberculosis | eng |
| dc.subject.ddc | 610 Medizin und Gesundheit | none |
| dc.title | Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023 | none |
| dc.type | article | |
| dc.identifier.urn | urn:nbn:de:0257-176904/13672-6 | |
| dc.type.version | publishedVersion | none |
| local.edoc.container-title | Eurosurveillance - Europe's journal on infectious disease surveillance, epidemiology, prevention and control | none |
| local.edoc.type-name | Zeitschriftenartikel | |
| local.edoc.container-type | periodical | |
| local.edoc.container-type-name | Zeitschrift | |
| local.edoc.container-publisher-name | European Centre for Disease Prevention and Control | none |
| local.edoc.container-reportyear | 2024 | none |
| local.edoc.container-firstpage | 1 | none |
| local.edoc.container-lastpage | 5 | none |
| dc.description.version | Peer Reviewed | none |
